Literature DB >> 14120826

SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE.

P SZEKELY.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS; AURICULAR FIBRILLATION; EMBOLISM; HEART SURGERY; MITRAL VALVE STENOSIS; PREVENTIVE MEDICINE; RHEUMATIC HEART DISEASE; STATISTICS

Mesh：

Substances：

Year:  1964        PMID： 14120826      PMCID： PMC1814317          DOI： 10.1136/bmj.1.5392.1209

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  13 in total

1.  The results of anticoagulant therapy in Norway.

Authors:  P A OWREN
Journal:  Arch Intern Med       Date:  1963-02

2.  Some clinical notes on patients with mitral valvular disease who have had mitral valvuloplasty. II.

Authors:  E RISS; S A LEVINE
Journal:  Am Heart J       Date:  1958-12       Impact factor: 4.749

3.  Systemic and pulmonary emboli before and after mitral commissurotomy.

Authors:  F KELLOGG; C K LIU; I W FISHMAN; R LARSON
Journal:  Circulation       Date:  1961-08       Impact factor: 29.690

4.  The risks of deferring valvotomy in patients with moderate mitral stenosis.

Authors:  R G BANNISTER
Journal:  Lancet       Date:  1960-08-13       Impact factor: 79.321

5.  [Arterial embolism in mitral stenosis and commissurotomy].

Authors:  G RICORDEAU; B COBLENTZ; J LENEGRE
Journal:  Arch Mal Coeur Vaiss       Date:  1957-02

6.  Prevention of systemic arterial embolism in chronic rheumatic heart disease by means of protracted anticoagulant therapy.

Authors:  J C WOOD; H L CONN
Journal:  Circulation       Date:  1954-10       Impact factor: 29.690

7.  An appreciation of mitral stenosis. I. Clinical features.

Authors:  P WOOD
Journal:  Br Med J       Date:  1954-05-08

8.  Systemic arterial embolism in rheumatic heart disease.

Authors:  R DALEY; T W MATTINGLY; C L HOLT; E F BLAND; P D WHITE
Journal:  Am Heart J       Date:  1951-10       Impact factor: 4.749

9.  Deterioration after mitral valvotomy.

Authors:  C P LOWTHER; R W TURNER
Journal:  Br Med J       Date:  1962-04-14

10.  Prophylaxis of recurrent embolism of intracardiac origin; protracted anticoagulant therapy on an ambulatory basis.

Authors:  S W COSGRIFF
Journal:  J Am Med Assoc       Date:  1950-07-08
View more
  45 in total

Review 1.  [Review of plasma anti-aggregants and their indications in primary care. Eight years later].

Authors:  M Blasco Valle; J F Lucía Cuesta
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

Review 2.  Use of oral anticoagulants in older patients.

Authors:  J L Sebastian; D D Tresch
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 3.  Why is warfarin underutilized in patients with atrial fibrillation?

Authors:  Greg C Flaker; John Schutz
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

4.  MITRAL STENOSIS AND SYSTEMIC EMBOLI.

Authors:  D LILLICRAP; A PIESOWICZ
Journal:  Br Med J       Date:  1964-11-07

5.  SYSTEMIC EMBOLISM IN MITRAL STENOSIS: RELATION TO THE SIZE OF THE LEFT ATRIAL APPENDIX.

Authors:  W SOMERVILLE; R J CHAMBERS
Journal:  Br Med J       Date:  1964-11-07

6.  EMBOLISM IN MITRAL VALVE DISEASE.

Authors:  E K MATTHEWS; J P QUILLIAM
Journal:  Br Med J       Date:  1964-11-07

7.  ENDOMYOCARDIAL FIBROSIS IN BRITAIN.

Authors:  M BLACK; J M FOWLER
Journal:  Br Med J       Date:  1965-03-13

Review 8.  Transesophageal echocardiography and stroke.

Authors:  Timothy D Woods
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

Review 9.  Antithrombotic treatment in atrial fibrillation.

Authors:  L Kalra; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

10.  Cerebral embolism and mitral stenosis: survival with and without anticoagulants.

Authors:  G F Adams; J D Merrett; W M Hutchinson; A M Pollock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.